Clinicopath Conf
Metastatic Malignant Melanoma, "Encephalitic"Form, in Leptomeninges and Cerebral Cortex, Case 28-199, , NE27:107-116,1992., 1992
Horizontal Diplopia Due to Extraocular Muscle Metastasis
Neurol 99:669-670, Atik, M.,et al, 2022
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Dural Melanocytoma with Leptomeningeal Melanocytosis
Neurol 88:e70-e71, Schembri, M.,et al, 2017
Neurocutaneous Melanosis with Diffuse Leptomeningeal Malignant Melanoma in an Adult
Neurol 86:e75-e79, Bhatia, R.,et al, 2016
Intracranial Lesions with High Signal Intensity on T1-weighted MR images - Review of Pathologies
Pol J Radiol 78:36-46, Zimmy, Anna.,et al, 2013
Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
Vemurafenib for Melanoma Metastases to the Brain
NEJM 365:2439-2441, Rochet, N.M.,et al, 2011
Leptomeningeal Metastases in the MRI Era
Neurol 74:1449-1454, Clarke,J.L., et al, 2010
Family History of Melanoma and Parkinson Disease Risk
Neurol 73:1286-1291, Gao,X.,et al, 2009
Improved Detection of Metastatic Melanoma by T2*-Weighted Imaging
AJNR 27:605-608, Gaviani,P.,et al, 2006
Primary Diffuse Meningeal Melanomatosis: Radiologic-Pathologic Correlation
AJNR 24:115-118, Pirini,M.,et al, 2003
Treatment of Brain Metastases of Malignant Melanoma with Temozolomide
NEJM 345:621-622, Biasco,G.,et al, 2001
MR Findings of a Primary Intramedullary Malignant Melanoma: Case Report and Literature Review
AJNR 22:1864-1866, Farrokh,D.,et al, 2001
Imaging Features of Intraventricular Melanoma
AJNR 20:691-693, Arbelaez,A.,et al, 1999
Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995
Intracranial Metastatic Melanoma:Correlation Between MR Imaging Characteristics and Melanin Content
AJR 165:1503-1512, Isiklar,I.,et al, 1995
Intracranial Metastatic Melanoma:Correlation Between MR Imaging Characteristics and Melanin Content
AJR 165:1503-1512, Isiklar,I.,et al, 1995
Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993
MR Imaging of Intracranial Metastatic Melanoma
J Comput Assist Tomogr 11:577-582, Atlas,S.W.,et al, 1987
Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985
Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985
Meningeal Carcinomatosis
Arch Neurol 38:696-699, Theodore,W.H.,et al, 1981
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974